Martin Shkreli, a hedgefunder who started a company called Turing Pharmaceuticals, who bought the rights to Daraprim, a drug which treats the effects of AIDS and until now cost $13.50 per pill. Shkreli made the decision to increase the price to $750 per pill in order to “turn a profit”.
The drug, which treats toxoplasmosis, had had a number of owners and has been around for more than 60 years. Having bought the rights to this critical anti-parasitic drug, Shkreli upped the price by more than 5,000%. His justification for the price increase is that some of the extra money earned from the drug will go towards research to find a more modern alternative.
This is sadly just a sign of a capitalist system in which even healthcare panders to corporate greed and not human need.